TRIUS THERAPEUTICS INC

Profile

Company Names

TRIUS THERAPEUTICS INC

Addresses

6310 NANCY RIDGE DRIVE, SUITE 105, SAN DIEGO, CA 92121

6310 NANCY RIDGE DR SUITE 105, SAN DIEGO, CA 92121

Phone Numbers

(858) 452-0370
858-452-0370

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$49,325,793.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-05-31 
$30,162,500.00 
$44,293,750.00 
$14,131,250.00 
Equity 
1
2009-11-05 
$19,163,293.00 
$30,000,000.00 
$10,836,707.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
G. 
ATWOOD 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  PHASERX INC   |  OPGEN INC   |  TRIUS THERAPEUTICS INC   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  VERSANT SIDE FUND II, LP   |  PHASERX, INC.   |  CLOVIS ONCOLOGY, INC.   |  VERACYTE, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
KENNETH 
 
BARTIZAL 
EXECUTIVE OFFICER
TRIUS THERAPEUTICS INC
KARIN 
 
EASTHAM 
DIRECTOR
TRIUS THERAPEUTICS INC   |  VERACYTE, INC.   |  VETICA LABS, INC.
JOHN 
 
FINN 
EXECUTIVE OFFICER
SOFT SWITCHING TECHNOLOGIES CORP   |  TRIUS THERAPEUTICS INC   |  BPL GLOBAL, LTD.   |  SAI ADVANCED POWER SOLUTIONS, INC.   |  TRAVUS THERAPEUTICS, INC.   |  ZOLO TECHNOLOGIES, INC.
DAVID 
 
KABAKOFF 
DIRECTOR
TRIUS THERAPEUTICS INC   |  ALLYLIX INC.   |  CEBIX INC   |  SOFINNOVA HEALTHQUEST PARTNERS, L.P.   |  LINEAGEN, INC   |  HERA THERAPEUTICS INC.   |  HEALTHQUEST PARTNERS II, L.P.   |  NEXTCURE, INC.   |  BIOTHERANOSTICS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  ANTIVA BIOSCIENCES, INC.   |  BIOCLIN THERAPEUTICS, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  RAINIER THERAPEUTICS, INC.   |  RARECYTE, INC.
DAVID 
S. 
KABAKOFF 
DIRECTOR
TRIUS THERAPEUTICS INC
NINA 
 
KJELLSON 
DIRECTOR
LYCERA CORP   |  PRIMERA BIOSYSTEMS INC   |  PRIMERADX, INC.   |  ALVINE PHARMACEUTICALS INC   |  SEQUEL PHARMACEUTICALS INC   |  CNS THERAPEUTICS INC   |  TRIUS THERAPEUTICS INC   |  CEBIX INCOPRATED   |  CEBIX INC   |  EIGER BIOPHARMACEUTICALS INC   |  OCERA THERAPEUTICS INC   |  WELLTOK, INC.   |  OCERA THERAPEUTICS, INC.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  ANNUM HEALTH, INC.   |  VINETI, INC.   |  TYRA BIOSCIENCES, INC.
NINA 
S. 
KJELLSON 
DIRECTOR
TRIUS THERAPEUTICS INC   |  LABRYS BIOLOGICS, INC.
MICHAEL 
 
MORNEAU 
EXECUTIVE OFFICER
TRIUS THERAPEUTICS INC   |  VIKING THERAPEUTICS, INC.
BRENDEN 
 
O-LEARY 
DIRECTOR
TRIUS THERAPEUTICS INC
MICHAEL 
 
POWELL 
DIRECTOR
ALVINE PHARMACEUTICALS INC   |  TRIUS THERAPEUTICS INC   |  ASCENTA THERAPEUTICS, INC.   |  ARCHIPELAGO LEARNING, INC.   |  OBJECTVIDEO INC   |  EXCELLENT ENERGY SOLUTIONS, LLC   |  SOFINNOVA VENTURE PARTNERS VIII, L.P.   |  MIRNA THERAPEUTICS, INC.   |  SUPPLY VISION, INC.   |  PASSPORT SYSTEMS INC   |  CATALYST BIOSCIENCES INC   |  CHIGWELL LTD   |  MERCURY MEDIA SCIENCE B LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  E-CIRCUIT MOTORS, INC.   |  PIONYR IMMUNOTHERAPEUTICS, INC.   |  TM TECHNOLOGIES INC   |  GALERA THERAPEUTICS, INC.   |  SYNLOGIC, INC.   |  AEOVIAN PHARMACEUTICALS, INC.
PHILIPPE 
 
PROKOCIMER 
EXECUTIVE OFFICER
TRIUS THERAPEUTICS INC
JOHN 
 
SCHMID 
EXECUTIVE OFFICER
TRIUS THERAPEUTICS INC   |  GREEN PARK DENVER, LLC   |  WINPRO PARKING,LLC   |  ANAPTYSBIO INC   |  POSEIDA THERAPEUTICS, INC.   |  DESIGN THERAPEUTICS, INC.   |  BELLWOOD COMMUNITY HOLDING CO.   |  AUTOBOOKS, INC.
JOHN 
P. 
SCHMID 
EXECUTIVE OFFICER
TRIUS THERAPEUTICS INC
THEODORE 
R. 
SCHROEDER 
DIRECTOR
INCLINE THERAPEUTICS, INC.   |  TRIUS THERAPEUTICS INC   |  SG PHARMACEUTICALS, INC.   |  ZAVANTE THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.
RISA 
 
STACK 
DIRECTOR
CORTHERA INC   |  HX DIAGNOSTICS INC   |  NEXUS DX, INC.   |  TRIUS THERAPEUTICS INC   |  NODALITY INC   |  NODALITY, INC.   |  CARDIODX INC   |  ITC NEXUS HOLDING COMPANY, INC.   |  MENLO MICROSYSTEMS, INC.   |  VINETI, INC.   |  METAGENOMI TECHNOLOGIES, LLC   |  PINKDX, INC.   |  BAKAR ENTREPRENEURSHIP FUND I, L.P.
JEFFREY 
 
STEIN 
EXECUTIVE OFFICER, DIRECTOR
TRIUS THERAPEUTICS INC   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  IDEAYA BIOSCIENCES, INC.   |  FRP INVESTORS, L.P.   |  TOMATO JOS, INC.
PAUL 
 
TRUEX 
DIRECTOR
TRIUS THERAPEUTICS INC   |  EIGER BIOPHARMACEUTICALS INC   |  MILESTONE PHARMACEUTICALS INC.
PAUL 
F. 
TRUEX 
DIRECTOR
TRIUS THERAPEUTICS INC   |  PROTAGONIST THERAPEUTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-06-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2011-05-31 
2009-11-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-11-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PIPER JAFFRAY + CO.
665